3-Aminobenzamide-a PARP inhibitor enhances the sensitivity of peripheral blood micronucleus and comet assays in mice

Toxicology Mechanisms and Methods

Volumn 24, Issue 5, 2014, Pages 332-341

  Shekh, Kamran ^a   Khan, Sabbir ^a   Jena, Gopabandhu ^a   Kansara, Bhavin R ^b   Kushwaha, Sapana ^c  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH MOHALI   (India)

^c CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

DNA damage; Genotoxicity; Poly(ADP ribose) polymerase; Weak genotoxins

Indexed keywords

3 AMINOBENZAMIDE; CYCLOPHOSPHAMIDE; FLUOROURACIL; FUROSEMIDE; ZIDOVUDINE; 3-AMINOBENZAMIDE; BENZAMIDE DERIVATIVE; MUTAGENIC AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; COMET ASSAY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; DNA REPAIR; ERYTHROCYTE; GENOTOXICITY; LIVER; MICRONUCLEUS; MICRONUCLEUS TEST; MOUSE; NONHUMAN; PERIPHERAL BLOOD MICRONUCLEUS ASSAY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RETICULOCYTE; TOXICITY TESTING; ANIMAL; ANTAGONISTS AND INHIBITORS; MALE; PROCEDURES; TOXICITY;

ANIMALS; BENZAMIDES; COMET ASSAY; CYCLOPHOSPHAMIDE; FLUOROURACIL; FUROSEMIDE; MALE; MICE; MICRONUCLEUS TESTS; MUTAGENS; POLY(ADP-RIBOSE) POLYMERASES; ZIDOVUDINE;

EID: 84900834826     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2014.898355     Document Type: Article

References (54)

1. Ahmad T, Shekh K, Khan S, et al. (2013). Pretreatment with valproic acid, a histone deacetylase inhibitor, enhances the sensitivity of the peripheral blood micronucleus assay in rodents. Mutat Res 751:19-26.
2. Al-Ejeh F, Shi W, Miranda M, et al. (2013). Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor. J Nucl Med 54:913-21.
3. Audebert M, Salles B, Calsou P. (2004). Involvement of Poly (ADPribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J Biol Chem 279: 55117-26. (Pubitemid 40066505)
4. Ayers KM. (1988). Preclinical toxicology of zidovudine. An overview. Am J Med 85:186-8.
5. Booth L, Cruickshanks N, Ridder T, et al. (2013). PARP and CHK inhibitors interact to cause DNA damage and cell death in mammary carcinoma cells. Cancer Biol Therapy 14:458-65.
6. Cepeda V, Fuertes MA, Castilla J, et al. (2006). Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy. Recent Pat Anticancer Drug Discov 1:39-53.
7. Croset A, Cordelieres FP, Berthault N, et al. (2013). Inhibition of DNA damage repair by artificial activation of PARP with si DNA. Nucleic Acids Res 41:7344-55.
8. Czapski GA, Cakala M, Gajkowska B, et al. (2006). Poly (ADP-ribose) polymerase-1 inhibition protects the brain against systemic inflammation. Neurochem Int 49:751-5. (Pubitemid 44648493)
9. D'Amours D, Desnoyers S, D'Silva I, et al. (1999). Poly (ADPribosyl) ation reactions in the regulation of nuclear functions. Biochem J 342:249-68. (Pubitemid 29425344)
10. Dertinger SD, Torous DK, Tometsko KR. (1996). Induction of micronuclei by low doses of azidothymidine (AZT). Mutat Res 368: 301-7. (Pubitemid 26232863)
11. Draft OECD Guideline for the Testing of Chemicals. (2012). Available at: http://www.oecd.org/env/ehs/testing/OECD-draft-Comet[1].pdf.
12. Do K, Chen AP. (2013). Molecular pathways: targeting PARP in cancer treatment. Clin Cancer Res 19:977-84.
13. European Food Safety Authority. (2012). Minimum criteria for the acceptance of in vivo alkaline comet assay reports. EFSA J 10:2977.
14. Evans TJ, Yamamoto KN, Hirota K, et al. (2010). Mutant cells defective in DNA repair pathways provide a sensitive high-throughput assay for genotoxicity. DNA Repair (Amst) 9:1292-8.
15. Hartlerode AJ, Scully R. (2009). Mechanisms of double-strand break repair in somatic mammalian cells. Biochem J 423:157-68.
16. Herceg Z, & Wang ZQ. (2001). Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death. Mutat Res 477:97-110. (Pubitemid 32480193)
17. ICH Harmonised Tripartite Guideline. (2011). Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use S2(R1). Available at: http://www.ich.org/fileadmin/Public-Web-Site/ICH-Products/ Guidelines/Safety/S2-R1/Step4/S2R1-Step4.pdf.
18. Jagtap P, Szabo C. (2005). Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4:421-40. (Pubitemid 40704125)
19. Kawaguchi S, Nakamura T, Yamamoto A, et al. (2010a). Is the comet assay a sensitive procedure for detecting genotoxicity? J Nucl Acids 28:541050.
20. Khan S, Jena G. (2014). Sodium valproate, a histone deacetylase inhibitor ameliorates cyclophosphamide-induced genotoxicity and cytotoxicity in the colon of mice. J Basic Clin Physiol Pharmacol 29:1-11.
21. Khan S, Ahmad T, Parekh CV. (2011). Investigation on sodium valproate induced germ cell damage, oxidative stress and genotoxicity in male Swiss mice. Reprod Toxicol 32:385-94.
22. Lim HK, Asharani PV, Hande MP. (2012). Enhanced genotoxicity of silver nanoparticles in DNA repair deficient Mammalian cells. Front Genet 3:104.
23. Liu X, Kramer JA, Swaffield JC, et al. (2008). Development of a highthroughput yeast-based assay for detection of metabolically activated genotoxins. Mutat Res 653:63-9.
24. Lord CJ, Ashworth A. (2008). Targeted therapy for cancer using PARP inhibitors. Curr Opin Pharmacol 8:363-9.
25. Martin NM. (2001). DNA repair inhibition and cancer therapy. J Photochem Photobiol B 63:162-70. (Pubitemid 33040734)
26. McLick J, Hakam A, Bauer PI, et al. (1987). Benzamide-DNA interactions: deductions from binding, enzyme kinetics and from X-ray structural analysis of a 9-ethyladenine-benzamide adduct. Biochim Biophys Acta 909:71-83. (Pubitemid 17087127)
27. Michels J, Vitale I, Saparbaev M, et al. (2013). Predictive biomarkers for cancer therapy with PARP inhibitors. Oncogene. doi: 10.1038/ onc.2013.352. [Epub ahead of print].
28. Mondal SC, Tripathi DN, Vikram A, et al. (2012). Furosemide-induced genotoxicity and cytotoxicity in the hepatocytes, but weak genotoxicity in the bone marrow cells of mice. Fundam Clin Pharmacol 26: 383-92.
29. Motimaya AM, Subramanya KS, Curry PT, et al. (1994). Lack of induction of micronuclei by azidothymidine (AZT) in vivo in mouse bone marrow cells. Environ Mol Mutagen 23:74-6. (Pubitemid 24125117)
30. Mughal A, Vikram A, Kushwaha S, et al. (2010). Simultaneous use of erythropoietin and prior bleeding enhances the sensitivity of the peripheral blood micronucleus assay. Mutagenesis 26:331-8.
31. Naya M, Mataki Y, Takahira H, et al. (1990). Effects of phorone and/or buthionine sulfoximine on teratogenicity of 5-fluorouracil in mice. Teratology 41:275-80. (Pubitemid 20093041)
32. O'Shaughnessy J, Osborne C, Pippen JE, et al. (2011). Iniparib plus chemotherapy in metastatic triple-negative breast cancer. N Engl J Med 364:205-14.
33. Oliver FJ, Menissier-de Murcia J, de Murcia G. (1999). Poly (ADPribose) polymerase in the cellular response to DNA damage, apoptosis, and disease. Am J Hum Genet 64:1282-8. (Pubitemid 30468745)
34. Pandya KG, Patel MR, Lau-Cam CA. (2010). Comparative study of the binding characteristics to and inhibitory potencies towards PARP and in vivo antidiabetogenic potencies of taurine, 3-aminobenzamide and nicotinamide. J Biomed Sci 17:S16.
35. Pfuhler S, Albertini S, Fautz R, et al. (2007). Genetic toxicity assessment: employing the best science for human safety evaluation. Part IV. Recommendation of a working group of the Gesellschaft fuer Umwelt- Mutationsforschung (GUM) for a simple and straightforward approach to genotoxicity testing. Toxicol Sci 97:237-40. (Pubitemid 47073841)
36. Purves D, Harvey C, Tweats D, et al. (1995). Genotoxicity testing: current practices and strategies used by the pharmaceutical industry. Mutagenesis 10:297-312.
37. Qiu YL, Wang W, Wang T, et al. (2011). DNA repair gene polymorphisms and micronucleus frequencies in Chinese workers exposed to vinyl chloride monomer. Int J Hyg Environ Health 214:225-30.
38. Robbins TJ, Bowen D. (1988). Toxicity, pathological effects, and antineoplastic activity of a non-toxic dose of 5-fluorouracil in combination with methotrexate. Anticancer Res 8:43-9.
39. Savill NJ, Chadwick W, Reece SE. (2009). Quantitative analysis of mechanisms that govern red blood cell age structure and dynamics during anaemia. PLoS Comput Biol 5:e1000416.
40. Shall S. (1995). ADP-ribosylation reactions. Biochimie 77:313-18.
41. Southan GJ, Szabo C. (2003). Poly(ADP-ribose) polymerase inhibitors. Curr Med Chem 10:321-40. (Pubitemid 36131664)
42. Ström C, Helleday T. (2012). Strategies for the use of poly(adenosine diphosphate ribose) polymerase (PARP) inhibitors in cancer therapy. Biomolecules 2:635-49.
43. Surjana D, Halliday GM, Damian DL. (2010). Role of nicotinamide in DNA damage, mutagenesis, and DNA repair. J Nucleic Acids. doi: 10.4061/2010/157591.
44. Swindall AF, Stanley JA, Yang ES. (2013). PARP-1: friend or foe of DNA damage and repair in tumorigenesis? Cancers (Basel) 5: 943-58.
45. Szabo C, Zingarelli B, O'Connor M, et al. (1996). DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA 93: 1753-8. (Pubitemid 26079829)
46. Torous DK, Hall NE, Illi-Love AH, et al. (2005). Interlaboratory validation of a CD71-based flow cytometric method (Microflow) for the scoring of micronucleated reticulocytes in mouse peripheral blood. Environ Mol Mutagen 45:44-55. (Pubitemid 40209394)
47. Vasquez MZ. (2010). Combining the in vivo comet and micronucleus assays: a practical approach to genotoxicity testing and data interpretation. Mutagenesis 25:187-99.
48. Vikram A, Ramarao P, Jena G. (2007). Prior bleeding enhances the sensitivity of peripheral blood and bone marrow micronucleus tests in rats. Mutagenesis 22:287-91. (Pubitemid 47216619)
49. Vikram A, Tripathi DN, Pawar AA, et al. (2008). Pre-bled-young-rats in genotoxicity testing: a model for peripheral blood micronucleus assay. Regul Toxicol Pharmacol 52:147-57.
50. Williams DP. (2006). Toxicophores: investigations in drug safety. Toxicology 226:1-11. (Pubitemid 44287158)
51. Williams DP, Antoine DJ, Butler PJ, et al. (2007). The metabolism and toxicity of furosemide in the Wistar rat and CD-1 mouse: a chemical and biochemical definition of the toxicophore. J Pharmacol Exp Ther 322:1208-20. (Pubitemid 47295823)
52. Zhao YJ, Wang JH, Fu B, et al. (2009). Effects of 3-aminobenzamide on expressions of poly (ADP ribose) polymerase and apoptosis inducing factor in cardiomyocytes of rats with acute myocardial infarction. Chin Med J (Engl) 122:1322-7.
53. Zhu S, Wang A, Xia Z. (2005). Polymorphisms of DNA repair gene XPD and DNA damage of workers exposed to vinylchloride monomer. Int J Hyg Environ Health 208:383-90. (Pubitemid 41213307)
54. Zingarelli B, O'Connor M, Wong H, et al. (1996). Peroxynitritemediated DNA strand breakage activates poly-adenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J Immunol 156: 350-8. (Pubitemid 26006983)